Abstract
The present disclosure relates to a novel crystalline forms of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile represented by the following structural formula-1, which is referred to as Resmetirom.
Formula-1.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Revu Satyanarayana, Kammari Balraju, Nomula Sathaiah, Rayavarapu Srinuvasa Rao; Garai Abhijit, Dodle Beerappa and Edulakanti Jhansi., "Solid-state forms of Resmetirom and processes for preparation thereof", Technical Disclosure Commons, (January 30, 2025)
https://www.tdcommons.org/dpubs_series/7790